Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Zeder (Graz, Austria), A. Avian (Graz, Austria), G. Bachmaier (Graz, Austria), P. Douschan (Graz, Austria), V. Foris (Graz, Austria), T. Sassmann (Graz, Austria), H. Olschewski (Graz, Austria), G. Kovacs (Graz, Austria). Pulmonary Vascular Resistances are Predictors of 3-year-survival in Systemic Sclerosis. 1514

Member's Comments

No comment yet.

Related content which might interest you: Exercise Pulmonary Vascular Resistances are Predictors of Survival in Systemic Sclerosis Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Pulmonary Hypertension in Pulmonary tuberculosis- A Prognostic Indicator Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Outcomes in embolisations of pulmonary arterio-venous malformations Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Exercise-induced pulmonary hypertension in patients with systemic sclerosis: Pilot-study Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Aerobic Training Improves Pulmonary and Systemic Inflammatory and Fibrotic Response in Asthmatics Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021 Long-term Outcome of Pulmonary Resection for Nontuberculous Mycobacterial Pulmonary Disease Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 Clinical Features of Pulmonary Hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 Multi-Omics Analysis of the PDGF Response in Pulmonary Vascular Smooth Muscle Cells from Patients with Pulmonary Arterial Hypertension: Implication of the NMDAR Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Prognosis factors of recurrent pulmonary thromboembolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Alteration of factors associated with coagulation in provoked pulmonary embolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Late Breaking Abstract - Clinical Efficacy and Safety of Macitentan Transitioned from Bosentan in Patients with Pulmonary Arterial Hypertension Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Combination of sPESI and cardiac troponin in the outpatient treatment of pulmoner thromboembolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 Isolated hypocapnia: A sign not to be neglected Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Clinical and Epidemiological Features of Tumor and Non-tumor Patients Complicated with Pulmonary Embolism Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017 Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 The impact of Initial Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism: a French prospective cohort. Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism Year: 2020